These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 9744780

  • 21. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V, Majello E, Testa A, Pezzella G, Giuseppe S, Giotta F, Riccardi F, Fortunato S, Colucci G, Gebbia N.
    Cancer; 1996 Sep 15; 78(6):1300-7. PubMed ID: 8826954
    [Abstract] [Full Text] [Related]

  • 22. [High-dose leucovorin and 5-fluorouracil in advanced gastric and colorectal cancer. High-Dose Leucovorin and 5-FU Study Group].
    Sasaki T, Ota K, Sakata Y, Matsuoka T, Wakui A, Akazawa S, Ogawa M, Mukaiyama T, Yoshino M, Sakai Y.
    Gan To Kagaku Ryoho; 1990 Dec 15; 17(12):2361-8. PubMed ID: 2260872
    [Abstract] [Full Text] [Related]

  • 23. A meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer.
    Chen ML, Fang CH, Liang LS, Dai LH, Wang XK.
    Surg Oncol; 2010 Mar 15; 19(1):38-45. PubMed ID: 19345093
    [Abstract] [Full Text] [Related]

  • 24. Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer.
    Conti JA, Kemeny NE, Saltz LB, André AM, Grossano DD, Bertino JR.
    Cancer; 1995 Feb 01; 75(3):769-74. PubMed ID: 7828126
    [Abstract] [Full Text] [Related]

  • 25. Second-line treatment of advanced colorectal cancer with a weekly simultaneous 24-hour infusion of 5-fluorouracil and sodium-folinate: a multicentre phase II trial.
    Kuhfahl J, Steinbrecher C, Wagner T, Wagner H, Fritze D, Link H, Schulte F, Pichlmeier U, Kreuser ED.
    Onkologie; 2004 Oct 01; 27(5):449-54. PubMed ID: 15585974
    [Abstract] [Full Text] [Related]

  • 26. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
    Klaassen U, Wilke H, Seeber S.
    J Infus Chemother; 1996 Oct 01; 6(3):127-32. PubMed ID: 9229323
    [Abstract] [Full Text] [Related]

  • 27. Systemic treatment options in advanced colorectal cancer: perspectives on combination 5-fluorouracil plus leucovorin.
    Grem JL.
    Semin Oncol; 1997 Oct 01; 24(5 Suppl 18):S18-8-S18-18. PubMed ID: 9420016
    [Abstract] [Full Text] [Related]

  • 28. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.
    Van Cutsem E, Twelves C, Cassidy J, Allman D, Bajetta E, Boyer M, Bugat R, Findlay M, Frings S, Jahn M, McKendrick J, Osterwalder B, Perez-Manga G, Rosso R, Rougier P, Schmiegel WH, Seitz JF, Thompson P, Vieitez JM, Weitzel C, Harper P, Xeloda Colorectal Cancer Study Group.
    J Clin Oncol; 2001 Nov 01; 19(21):4097-106. PubMed ID: 11689577
    [Abstract] [Full Text] [Related]

  • 29. Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group.
    Cocconi G, Cunningham D, Van Cutsem E, Francois E, Gustavsson B, van Hazel G, Kerr D, Possinger K, Hietschold SM.
    J Clin Oncol; 1998 Sep 01; 16(9):2943-52. PubMed ID: 9738562
    [Abstract] [Full Text] [Related]

  • 30. Hand-foot syndrome induced by high-dose, short-term, continuous 5-fluorouracil infusion.
    Chiara S, Nobile MT, Barzacchi C, Sanguineti O, Vincenti M, Di Somma C, Meszaros P, Rosso R.
    Eur J Cancer; 1997 May 01; 33(6):967-9. PubMed ID: 9291822
    [Abstract] [Full Text] [Related]

  • 31. A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer. The Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).
    Aranda E, Cervantes A, Dorta J, Blanco E, Fernández-Martos C, Cruz-Hernandez JJ, Carrato A, Gonzalez-Mancha R, García-Conde J, Díaz-Rubio E.
    Cancer; 1995 Aug 15; 76(4):559-63. PubMed ID: 8625147
    [Abstract] [Full Text] [Related]

  • 32. Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients.
    Guglielmi A, Aschele C, Grossi F, Tixi L, Sobrero A.
    Cytotechnology; 1996 Aug 15; 19(3):215-9. PubMed ID: 8862009
    [Abstract] [Full Text] [Related]

  • 33. Association of adverse events and survival in colorectal cancer patients treated with adjuvant 5-fluorouracil and leucovorin: Is efficacy an impact of toxicity?
    Soveri LM, Hermunen K, de Gramont A, Poussa T, Quinaux E, Bono P, André T, Österlund P.
    Eur J Cancer; 2014 Nov 15; 50(17):2966-74. PubMed ID: 25266443
    [Abstract] [Full Text] [Related]

  • 34. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.
    Hoff PM, Ansari R, Batist G, Cox J, Kocha W, Kuperminc M, Maroun J, Walde D, Weaver C, Harrison E, Burger HU, Osterwalder B, Wong AO, Wong R.
    J Clin Oncol; 2001 Apr 15; 19(8):2282-92. PubMed ID: 11304782
    [Abstract] [Full Text] [Related]

  • 35. Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancer.
    Goldberg RM, Hatfield AK, Kahn M, Sargent DJ, Knost JA, O'Connell MJ, Krook JE, Maillard JA, Wiesenfeld M, Schaefer PL, Tirona MT, Moertel CG.
    J Clin Oncol; 1997 Nov 15; 15(11):3320-9. PubMed ID: 9363861
    [Abstract] [Full Text] [Related]

  • 36. Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study.
    Scheithauer W, Kornek G, Marczell A, Salem G, Karner J, Kovats E, Burger D, Greiner R, Pidlich J, Schneeweiss B, Raderer M, Rosen H, Depisch D.
    J Clin Oncol; 1997 Mar 15; 15(3):908-14. PubMed ID: 9060527
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. 5-methyltetrahydrofolate for biochemical modulation of fluorouracil (FU) in patients with advanced colorectal cancer: a randomized phase I-II study of two different FU administration schedules.
    Hejna M, Kornek GV, Raderer M, Valencak J, Weinländer G, Fiebiger W, Miholic J, Scheithauer W.
    Ann Oncol; 1998 Dec 15; 9(12):1309-14. PubMed ID: 9932161
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.